Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 19;13(6):1756.
doi: 10.3390/jcm13061756.

The Influence of Hyperthyroidism on the Coagulation and on the Risk of Thrombosis

Nebojsa Antonijevic  1   2 , Dragan Matic  1   2 , Biljana Beleslin  2   3 , Danijela Mikovic  4 , Zaklina Lekovic  1 , Marija Marjanovic  1 , Ana Uscumlic  1   2 , Ljubica Birovljev  1 , Branko Jakovljevic  2   5
Affiliations

The Influence of Hyperthyroidism on the Coagulation and on the Risk of Thrombosis

Nebojsa Antonijevic et al. J Clin Med. .

Abstract

Introduction: Apart from the well-known fact that hyperthyroidism induces multiple prothrombotic disorders, there is no consensus in clinical practice as to the impact of hyperthyroidism on the risk of thrombosis. The aim of this study was to examine the various hemostatic and immunologic parameters in patients with hyperthyroidism. Methods: Our study consists of a total of 200 patients comprised of 64 hyperthyroid patients, 68 hypothyroid patients, and 68 euthyroid controls. Patient thyroid status was determined with standard tests. Detailed hemostatic parameters and cardiolipin antibodies of each patient were determined. Results: The values of factor VIII (FVIII), the Von Willebrand factor (vWF), fibrinogen, plasminogen activator inhibitor-1 (PAI-1), and anticardiolipin antibodies of the IgM class were significantly higher in the hyperthyroid patients than in the hypothyroid patients and euthyroid controls. The rate of thromboembolic manifestations was much higher in hyperthyroid patients (6.25%) than in hypo-thyroid patients (2.9%) and euthyroid controls (1.4%). Among hyperthyroid patients with an FVIII value of ≥1.50 U/mL, thrombosis was recorded in 8.3%, while in hyperthyroid patients with FVIII value ≤ 1.50 U/mL the occurrence of thrombosis was not recorded. The incidence of atrial fibrillation (AF) was significantly higher (8.3%) in the hyperthyroid patients compared to the hypothyroid patients (1.5%) and euthyroid controls (0%). Conclusions: High levels of FVIII, vWF, fibrinogen, PAI-1, and anticardiolipin antibodies along with other hemostatic factors contribute to the presence of a hypercoaguable state in patients with hyperthyroidism. The risk of occurrence of thrombotic complications is especially pronounced in patients with a level of FVIII exceeding 150% and positive anticardiolipin antibodies of the IgM class. Patients with AF are at particularly high risk of thrombotic complications due to a hyperthyroid prothrombotic milieu.

Keywords: hyperthyroidism; prothrombotic; risk of thrombosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Fibrinogen and Natural Anticoagulant Values in Relation to Thyroid Status.
Figure 2
Figure 2
Fibrinolytic System Parameter Values in Relation to Thyroid Status.
See this image and copyright information in PMC

References

    1. Wang Y., Ding C., Guo C., Wang J., Liu S. Association between thyroid dysfunction and venous thromboembolism: A systematic review and meta-analysis. Medicine. 2023;102:e33301. doi: 10.1097/MD.0000000000033301. - DOI - PMC - PubMed
    1. Elbers L.P.B., Fliers E., Cannegieter S.C. The influence of thyroid function on the coagulation system and its clinical consequences. J. Thromb. Haemost. 2018;16:634–645. doi: 10.1111/jth.13970. - DOI - PubMed
    1. Stuijver D.J., van Zaane B., Romualdi E., Brandjes D.P., Gerdes V.E., Squizzato A. The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: A systematic review and meta-analysis. Thromb. Haemost. 2012;108:1077–1088. - PubMed
    1. Debeij J., van Zaane B., Dekkers O.M., Doggen C.J., Smit J.W., van Zanten A.P., Brandjes D.P., Büller H.R., Gerdes V.E., Rosendaal F.R., et al. High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: The MEGA study. J. Thromb. Haemost. 2014;12:839–846. doi: 10.1111/jth.12573. - DOI - PubMed
    1. Davis P.J., Mousa S.A., Schechter G.P. New Interfaces of Thyroid Hormone Actions with Blood Coagulation and Thrombosis. Clin. Appl. Thromb. Hemost. 2018;24:1014–1019. doi: 10.1177/1076029618774150. - DOI - PMC - PubMed

LinkOut - more resources